Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Kyobo Securities Co ., Ltd (030610.KS)
Seoul, KR
Kyobo Securities Co., Ltd., a financial institution headquartered in Seoul, South Korea, delivers a broad spectrum of investment and financial services. Founded in 1949 as Daehan Securities Co., Ltd. and adopting its current name in April 1994, the company operates as a subsidiary of Kyobo Life Insurance Co., Ltd. It offers specialized project-related financial solutions, encompassing project financing, structured finance, mergers and acquisitions (M&A) advisory, and direct investment services. For corporate clients, Kyobo Securities facilitates fundraising through instruments like mezzanine bonds (including convertible bonds and participating preferred stock), manages public and private corporate bond placements, designs intricate project financing structures, and supports initial public offerings (IPOs). The firm also provides essential funding for diverse development initiatives, spanning real estate, local government projects, social overhead capital (SOC), and green energy. Its extensive brokerage services are accessible both online and offline, covering a wide range of futures products—such as indices, currencies, energy, interest rates, metals, and agricultural commodities—in addition to fixed income brokerage for individuals, institutions, foundations, and corporations. Furthermore, the company is involved in the issuance, intermediation, and oversight of derivative-linked bonds and structured securities, acts as a broker for various equity-linked instruments (stocks, derivatives, futures, and options), and offers comprehensive wealth management, customer asset management, and risk management services to both institutional and retail clientele.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -4.39% | -15.34% | -2.35% | -19.32% | +35.23% | +37.10% | +80.62% | +142.64% | +45.48% | +28.60% | +108.43% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Asset Management: +13.3%+27.5% ★ Q1'26: +24.7% (vs Q1'25)
-
EPS growth Asset Management: +19.3%+21.4% ★ Q1'26: +32.2% (vs Q1'25)
-
FCF margin Asset Management: +27.4%-77.2% Q1'26: -157.9% (vs Q1'25)
-
EBIT margin Asset Management: +53.6%+47.5% Q1'26: +57.1% (vs Q1'25)
-
ROIC Asset Management: +5.7%+3.7% Q1'26: +5.3% (vs Q1'25)
-
Share dilution Asset Management: +0.0%+0.1% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Asset Management: 0.00×17.29× ★ Q1'26: 12.01× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | B- | 2/5 | 1/5 | 2/5 | 3/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-14 | B- | 2/5 | 1/5 | 2/5 | 3/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-13 | B- | 2/5 | 1/5 | 2/5 | 3/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-12 | B- | 2/5 | 1/5 | 2/5 | 3/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-11 | B- | 3/5 | 1/5 | 2/5 | 3/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-08 | B- | 3/5 | 1/5 | 2/5 | 3/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-07 | B- | 3/5 | 1/5 | 2/5 | 3/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-06 | B- | 3/5 | 1/5 | 2/5 | 3/5 | 1/5 | 4/5 | 4/5 |
| 2026-05-04 | B- | 3/5 | 1/5 | 2/5 | 3/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-30 | B- | 3/5 | 1/5 | 2/5 | 3/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-29 | B | 3/5 | 1/5 | 3/5 | 3/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-28 | B | 3/5 | 1/5 | 3/5 | 3/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-27 | B | 3/5 | 1/5 | 3/5 | 3/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-24 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-23 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-22 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-21 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-20 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-17 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-16 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-15 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-14 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-13 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
| 2026-04-10 | B | 3/5 | 1/5 | 3/5 | 4/5 | 1/5 | 4/5 | 4/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jung-Gyu Lim | MD & Head of Structured Investment Finance Division | 2B | male |
| Nam-Lee Lee | Director, Bond Finance Head & DCM Head | 2B | male |
| Won Il Choi | Executive Director & Head of Structured Finance Division | 1B | male |
| Sung Joon Lee | Director & Head of Investment Finance Division | 1B | male |
| Bongkwon Park | CEO & Executive Director | 989M | male |
| Seok-Gi Lee | CEO & Executive Director | 989M | male |
| Eun Kyu Kang | MD, Head of Derivative Finance Division and Sales & Trading Head | 919M | male |
| Young Kyun Shin | MD, Head of International Finance Headquarters & Head of General Finance Headquarters | — | male |
| Hyun Soo Park | Human Resources Manager & Compliance Officer | — | male |
| Jong-Gil Park | MD & Head of IB Division | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 030610.KS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
